Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,992,944 papers from all fields of science
Search
Sign In
Create Free Account
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2
Known as:
AIMAH2
, PRIMARY MACRONODULAR ADRENAL HYPERPLASIA
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
ARMC5, 1-BP DEL, G
ARMC5, ARG593TRP
ARMC5, LEU548PRO
Autosomal dominant inheritance
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
ARMC5 mutations are associated with high levels of proliferating cell nuclear antigen and the presence of the serotonin receptor 5HT4R in PMAH nodules
B. Conceição
,
I. Cavalcante
,
+5 authors
C. Lotfi
Archives of Endocrinology and Metabolism
2020
Corpus ID: 215407917
ABSTRACT Objective To analyze the morphological and functional characteristics of primary macronodular adrenal hyperplasia (PMAH…
Expand
Review
2019
Review
2019
Molecular and cellular regulation of primary macronodular adrenal hyperplasia
M. Fragoso
,
C. Lotfi
Current Opinion in Endocrine and Metabolic…
2019
Corpus ID: 201982306
2019
2019
MP69-04 A NEW INSIGHT FOR THE TREATMENT OF PRIMARY MACRONODULAR ADRENAL HYPERPLASIA: ADRENAL SPARING SURGERY EARLY OUTCOMES
F. Tanno
,
M. Fragoso
,
+7 authors
J. Chambo
Journal of Urology
2019
Corpus ID: 149867839
INTRODUCTION AND OBJECTIVES: Primary macronodular adrenal hyperplasia (PMAH) is a rare cause of Cushing’s syndrome (CS…
Expand
Review
2016
Review
2016
Etiopathogeny of Primary Adrenal Hypercortisolism.
F. Vélayoudom-Céphise
,
M. Haissaguerre
,
A. Tabarin
Frontiers of Hormone Research
2016
Corpus ID: 24808978
Primary adrenal hypercortisolism is mainly due to cortisol-producing adrenocortical adenomas, bilateral micronodular or…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE